Procept Biorobotics Corp (PRCT) Stock Price, Quote & News

Company Profile

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower u...

Industry: Medical Devices

Sector: Healthcare

Phone: 650 232 7200

Website: www.procept-biorobotics.com

Address:

150 Baytech Drive, San Jose, United States

AStateofTrance7 Apr. 6 at 8:55 AM

$PRCT

0 · Reply

Wisenheimer Apr. 3 at 3:00 AM

$PRCT anyone hearing recent cpt1 billing issues and what is causing it?

0 · Reply

NasdaqPulse Mar. 30 at 11:45 AM

SMALL CAP ACTIVE 5🚨-2 Small-cap watchlist for both portfolios. High volatility, high narrative. Trade accordingly. 👉Click to view @NasdaqPulse for timely updates amid the volatility. 1. $ONDS — $8.80 (-4.7% Fri) / 52-wk range $0.66–15.28 605% YoY revenue growth in 2025, guidance reset to $375M+ for 2026 2. $RR — $2.00 Fri close / 52-wk range $1.69–7.43 Class action lawsuit deadline April 3. Alleged "fabricated Microsoft agreement" — stock down 20%+ after MSFT denied partnership. High-risk distressed play. 3. $OSCR — $11.14 Fri close / 52-wk range $11.21–23.74 D2C health insurance with AI integration. Q4 revenue $2.8B (+17% YoY). 4. $CIFR — $13.74 Fri close / 52-wk range $1.86–25.52 Bitcoin miner → AI/HPC pivot. Mar 23: $200M credit line + long-term hyperscale data center deal. 5. $PRCT — $26.36 Fri close / 52-wk range $19.35–66.85 Surgical robotics (BPH: Aquablation). Recent Q4 miss → lowered 2026 guidance ($390-410M vs prior $410-430M).

0 · Reply

Jabrontinoooooooo Mar. 27 at 7:25 PM

$PRCT MED TECH @THE_Monkey_Banana_Genius pls pls save me obiwan

1 · Reply

Thelonius_Stonk Mar. 27 at 7:07 PM

$PRCT

1 · Reply

tkathlina Mar. 27 at 4:05 PM

$PRCT down from $60, pullback over?? 👀

0 · Reply

NeveREn0ugH Mar. 26 at 2:28 PM

$PRCT i want this back for $20

0 · Reply

THE_Monkey_Banana_Genius Mar. 23 at 6:52 PM

$PRCT added it back. Long

0 · Reply

BioGem Mar. 23 at 6:52 AM

$PRCT Despite the pump by the insider, the fundamentals are quite terrible and what I said holds; keep on shorting.

0 · Reply

Tony_37 Mar. 22 at 10:29 PM

$PRCT : $24-$25 💎

0 · Reply

EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH

Mar 12, 2026, 9:00 AM EDT - 25 days ago

PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy

Mar 8, 2026, 7:40 PM EDT - 4 weeks ago

PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm

Feb 26, 2026, 4:55 PM EST - 5 weeks ago

Ademi LLP Investigates Claims of Securities Fraud against PROCEPT BioRobotics Corporation

Feb 26, 2026, 7:55 AM EST - 5 weeks ago

PROCEPT BioRobotics® Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term Growth

Feb 26, 2026, 7:04 AM EST - 5 weeks ago

PROCEPT BioRobotics Stock Hits 52-Week Low - Here's Why

Feb 25, 2026, 4:02 PM EST - 5 weeks ago

PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance

Feb 23, 2026, 4:03 PM EST - 6 weeks ago

PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day

Feb 4, 2026, 4:03 PM EST - 2 months ago

PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference

Jan 26, 2026, 4:03 PM EST - 2 months ago

PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City

Nov 20, 2025, 4:03 PM EST - 4 months ago

PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025

Nov 4, 2025, 4:03 PM EST - 5 months ago

PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance

Oct 15, 2025, 4:03 PM EDT - 6 months ago

PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025

Aug 6, 2025, 4:03 PM EDT - 8 months ago

PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Jul 24, 2025, 6:00 PM EDT - 9 months ago

PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO

Jul 23, 2025, 8:00 AM EDT - 9 months ago

Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy

Jul 21, 2025, 4:03 PM EDT - 9 months ago

PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 14, 2025, 9:15 PM EDT - 9 months ago

Aquablation® Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

May 17, 2025, 7:00 AM EDT - 11 months ago

19 stocks at the intersection of AI and robotics that could see big sales boosts

AI AMBA CLS HSAI IOT ISRG NOW

Apr 29, 2025, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June

Apr 24, 2025, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops

Apr 24, 2025, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Apr 10, 2025, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

Mar 24, 2025, 8:00 AM EDT - 1 year ago

WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation

Mar 14, 2025, 8:00 AM EDT - 1 year ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada

Feb 25, 2025, 4:02 PM EST - 1 year ago

PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results

Feb 7, 2025, 8:00 AM EST - 1 year ago

PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

Jan 16, 2025, 9:00 AM EST - 1 year ago

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on PROCEPT BioRobotics (NASDAQ: PRCT)

Nov 26, 2024, 4:05 PM EST - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

Oct 29, 2024, 8:43 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

Oct 28, 2024, 4:19 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

Oct 28, 2024, 2:17 PM EDT - 1 year ago

Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential

Oct 28, 2024, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

Oct 9, 2024, 4:04 PM EDT - 1 year ago

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

Oct 7, 2024, 4:04 PM EDT - 1 year ago

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

Aug 28, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

Aug 21, 2024, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

Aug 1, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance

Jul 15, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024

Jun 17, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy

Jun 3, 2024, 4:03 PM EDT - 2 years ago

PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024

May 13, 2024, 4:05 PM EDT - 2 years ago

PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference

May 6, 2024, 8:00 AM EDT - 2 years ago

Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia

May 1, 2024, 7:00 AM EDT - 2 years ago

PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

AStateofTrance7 Apr. 6 at 8:55 AM

$PRCT

0 · Reply

Wisenheimer Apr. 3 at 3:00 AM

$PRCT anyone hearing recent cpt1 billing issues and what is causing it?

0 · Reply

NasdaqPulse Mar. 30 at 11:45 AM

0 · Reply

Jabrontinoooooooo Mar. 27 at 7:25 PM

$PRCT MED TECH @THE_Monkey_Banana_Genius pls pls save me obiwan

1 · Reply

Thelonius_Stonk Mar. 27 at 7:07 PM

$PRCT

1 · Reply

tkathlina Mar. 27 at 4:05 PM

$PRCT down from $60, pullback over?? 👀

0 · Reply

NeveREn0ugH Mar. 26 at 2:28 PM

$PRCT i want this back for $20

0 · Reply

THE_Monkey_Banana_Genius Mar. 23 at 6:52 PM

$PRCT added it back. Long

0 · Reply

BioGem Mar. 23 at 6:52 AM

$PRCT Despite the pump by the insider, the fundamentals are quite terrible and what I said holds; keep on shorting.

0 · Reply

Tony_37 Mar. 22 at 10:29 PM

$PRCT : $24-$25 💎

0 · Reply

ZRadly Mar. 22 at 4:09 PM

$PRCT Riding this and yes with a stop order in place😉 Cant lose now. Aloha

0 · Reply

Thelonius_Stonk Mar. 19 at 2:57 PM

$PRCT had to slap it

0 · Reply

JasonCO Mar. 17 at 1:50 PM

$PRCT slap for $40

0 · Reply

THE_Monkey_Banana_Genius Mar. 16 at 8:54 PM

$PRCT the beast has bottomed, allegedly

0 · Reply

Thelonius_Stonk Mar. 16 at 8:04 PM

$PRCT sumbitch refuses to give dips worth buying. prob nothing

0 · Reply

THE_Monkey_Banana_Genius Mar. 11 at 7:42 PM

$PRCT trimming 1/4 for quick 10%

0 · Reply

healthcareguru Mar. 11 at 4:05 PM

$PRCT shorting this garbage…their LRP targets are highly risky. Hearing more negative chatter from docs on intra-op bleeding and their Prostate cancer moonshot will never happen. $15 PT. 👎 $XLV $IHI $IWM

1 · Reply

Thelonius_Stonk Mar. 11 at 3:05 PM

$PRCT looks like major bottom in thnx @Monkey_MRNA_Genius only one

1 · Reply

EliasH51 Mar. 10 at 8:02 PM

$PRCT buddy works for this company and when I tell you getting hired is like a navy seals mental test I’d be downplaying it. If they have one competitive advantage, their sales team is the elite of the elite.

0 · Reply

Jabrontinoooooooo Mar. 10 at 4:52 PM

$PRCT I’m in following the geniuses

1 · Reply

THE_Monkey_Banana_Genius Mar. 10 at 1:59 PM

$PRCT starter 25s

0 · Reply

THE_Monkey_Banana_Genius Mar. 9 at 11:33 PM

$PRCT big insider buys. Time for me to get back in.

3 · Reply

Market Cap	1.42B
Revenue (ttm)	308.05M
Net Income (ttm)	-95.57M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-31.02%
Debt to Equity Ratio	0.14

Volume	1,757,000
Avg Vol	1,733,152
Day's Range	N/A - N/A
Shares Out	56.39M
Stochastic %K	1%
Beta	0.94
Analysts	Strong Sell
Price Target	$30.40